# Esperion Therapeutics (stock symbol: ESPR) Logo in transparent PNG and SVG formats

## Esperion Therapeutics Logo large

### Esperion Therapeutics Logo large Download PNG (25.6 KB)

![Esperion Therapeutics Logo large Download PNG (25.6 KB)](/img/orig/ESPR_BIG-c5b43dd6.png)

### Esperion Therapeutics Logo large Download SVG (4.57 KB)

![Esperion Therapeutics Logo large Download SVG (4.57 KB)](/img/orig/ESPR_BIG-3cc8082f.svg)

## Esperion Therapeutics Logo icon format

### Esperion Therapeutics Logo icon format Download PNG (5.9 KB)

![Esperion Therapeutics Logo icon format Download PNG (5.9 KB)](/img/orig/ESPR-16de76fc.png)

### Esperion Therapeutics Logo icon format Download SVG (476 Bytes)

![Esperion Therapeutics Logo icon format Download SVG (476 Bytes)](/img/orig/ESPR-d4af4149.svg)

## Esperion Therapeutics Logo large for dark backgrounds

### Esperion Therapeutics Logo large for dark backgrounds Download PNG (18.99 KB)

![Esperion Therapeutics Logo large for dark backgrounds Download PNG (18.99 KB)](/img/orig/ESPR_BIG.D-7cb1d14c.png)

### Esperion Therapeutics Logo large for dark backgrounds Download SVG (4.56 KB)

![Esperion Therapeutics Logo large for dark backgrounds Download SVG (4.56 KB)](/img/orig/ESPR_BIG.D-f66e67c4.svg)

## Esperion Therapeutics Logo icon format for dark backgrounds

### Esperion Therapeutics Logo icon format for dark backgrounds Download PNG (6.18 KB)

![Esperion Therapeutics Logo icon format for dark backgrounds Download PNG (6.18 KB)](/img/orig/ESPR.D-d1ce1d27.png)

### Esperion Therapeutics Logo icon format for dark backgrounds Download SVG (363 Bytes)

![Esperion Therapeutics Logo icon format for dark backgrounds Download SVG (363 Bytes)](/img/orig/ESPR.D-50291871.svg)

## About Esperion Therapeutics

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

1. Website domain: esperion.com
2. Employees: 218
3. Marketcap: $0.11 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
